Intracranial Response of ALK+ Non-Small-cell Lung Cancer to Second-line Dose-escalated Brigatinib After Alectinib Discontinuation Due to Drug-induced Hepatitis and Relapse After Whole Brain Radiotherapy Followed by Stereotactic Radiosurgery

被引：7
作者：
Urbanska, Edyta Maria [1 ]
Santoni-Rugiu, Eric [2 ,3 ]
Melchior, Linea Cecilie [2 ]
Carlsen, Jonathan Frederik [4 ]
Sorensen, Jens Benn [1 ]
机构：
[1] Univ Copenhagen, Dept Oncol, Rigshosp, Copenhagen, Denmark
[2] Univ Copenhagen, Rigshosp, Dept Pathol, Copenhagen, Denmark
[3] Univ Copenhagen, Biotech Res & Innovat Ctr BRIC, Copenhagen, Denmark
[4] Univ Copenhagen, Rigshosp, Dept Radiol, Copenhagen, Denmark
来源：
CLINICAL LUNG CANCER | 2021年 / 22卷 / 04期
关键词：
Alectinib hepatotoxicity; ALK; CNS efficacy of brigatinib; CNS relapse; Dose-escalated brigatinib; CRIZOTINIB;
D O I：
10.1016/j.cllc.2020.04.012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：E528 / E532
页数：5
相关论文
共 15 条
[1]  
Camidge DR, 2019, J THORAC ONCOL, V20, P30210
[2]  
Cordova Christine, 2017, J Thorac Oncol, V12, pe188, DOI 10.1016/j.jtho.2017.07.029
[3]   Alectinib Dose Escalation Reinduces Central Nervous System Responses in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Relapsing on Standard Dose Alectinib [J].
Gainor, Justin F. ;
Chi, Andrew S. ;
Logan, Jennifer ;
Hu, Ranliang ;
Oh, Kevin S. ;
Brastianos, Priscilla K. ;
Shih, Helen A. ;
Shaw, Alice T. .
JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (02) :256-260
[4]   Brigatinib Activity in Patients with ALK plus NSCLC and Intracranial CNS Metastases in Two Clinical Trials [J].
Gettinger, Scott ;
Kim, Dong-Wan ;
Tiseo, Marcello ;
Langer, Corey ;
Ahn, Myung-Ju ;
Shaw, Alice ;
Huber, Rudolf ;
Hochmair, Maximilian ;
Kim, Sang-We ;
Bazhenova, Lyudmila ;
Gold, Kathryn ;
Ou, Sai-Hong ;
West, Howard ;
Reichmann, William ;
Haney, Jeff ;
Clackson, Tim ;
Haluska, Frank ;
Kerstein, David ;
Camidge, D. Ross .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :S273-S274
[5]   Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial [J].
Hida, Toyoaki ;
Nokihara, Hiroshi ;
Kondo, Masashi ;
Kim, Young Hak ;
Azuma, Koichi ;
Seto, Takashi ;
Takiguchi, Yuichi ;
Nishio, Makoto ;
Yoshioka, Hiroshige ;
Imamura, Fumio ;
Hotta, Katsuyuki ;
Watanabe, Satoshi ;
Goto, Koichi ;
Satouchi, Miyako ;
Kozuki, Toshiyuki ;
Shukuya, Takehito ;
Nakagawa, Kazuhiko ;
Mitsudomi, Tetsuya ;
Yamamoto, Nobuyuki ;
Asakawa, Takashi ;
Asabe, Ryoichi ;
Tanaka, Tomohiro ;
Tamura, Tomohide .
LANCET, 2017, 390 (10089) :29-39
[6]   Imatinib dose escalation versus sunitinib as a second-line treatment against advanced gastrointestinal stromal tumors: A nationwide population-based cohort study [J].
Hsu, Jun-Te ;
Le, Puo-Hsien ;
Kuo, Chang-Fu ;
Chiou, Meng-Jiun ;
Kuo, Chia-Jung ;
Chen, Tsung-Hsing ;
Lin, Chun-Jung ;
Chen, Jen-Shi ;
Yu, Huang-Pin ;
Yeh, Chun-Nan ;
Jan, Yi-Yin ;
Yeh, Ta-Sen .
ONCOTARGET, 2017, 8 (41) :71128-71137
[7]   Activity and safety of brigatinib (BRG) in patients (pts) with ALK plus non-small cell lung cancer (NSCLC): Phase (ph) 1/2 trial results. [J].
Langer, Corey J. ;
Gettinger, Scott N. ;
Bazhenova, Lyudmila ;
Salgia, Ravi ;
Gold, Kathryn A. ;
Rosell, Rafael ;
Shaw, Alice Tsang ;
Weiss, Glen J. ;
Dorer, David J. ;
Rivera, Victor M. ;
Haluska, Frank G. ;
Kerstein, David ;
Camidge, D. Ross .
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[8]   Dose escalation can maximize therapeutic potential of sunitinib in patients with metastatic renal cell carcinoma [J].
Maraz, Aniko ;
Cserhati, Adrienn ;
Uhercsak, Gabriella ;
Szilagyi, Eva ;
Varga, Zoltan ;
Revesz, Janos ;
Koszo, Renata ;
Varga, Linda ;
Kahan, Zsuzsanna .
BMC CANCER, 2018, 18
[9]  
Ornstein MC, 2017, CLIN GENITOURIN CANC, V15, P275
[10]   Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer [J].
Peters, Solange ;
Camidge, D. Ross ;
Shaw, Alice T. ;
Gadgeel, Shirish ;
Ahn, Jin S. ;
Kim, Dong-Wan ;
Ou, Sai-Hong I. ;
Perol, Maurice ;
Dziadziuszko, Rafal ;
Rosell, Rafael ;
Zeaiter, Ali ;
Mitry, Emmanuel ;
Golding, Sophie ;
Balas, Bogdana ;
Noe, Johannes ;
Morcos, Peter N. ;
Mok, Tony .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :829-838
12